76 results
8-K
ALGS
Aligos Therapeutics Inc
22 May 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:02pm
”), resigned from the Board.
Following Mr. Nielsen’s departure, a vacancy was created on the Company’s Audit Committee, resulting in there being two … members of the Audit Committee (the “Vacancy”). Nasdaq Stock Market LLC Listing Rule 5605(c)(2)(A) requires that the Company have an Audit Committee
DEFA14A
ALGS
Aligos Therapeutics Inc
29 Apr 24
Additional proxy soliciting materials
4:04pm
; 1.01 Lawrence M. Blatt, Ph.D
1.02 James Scopa
2. The ratification of the appointment, by the Audit Committee of our board of directors, of Ernst
PRE 14A
k7px6xwhus4485pnrx95
16 Apr 24
Preliminary proxy
5:27pm
424B3
4qf2v
28 Nov 23
Prospectus supplement
4:01pm
8-K
EX-10.1
t75 zbnnmn1t1qxca
25 Oct 23
Entry into a Material Definitive Agreement
5:05pm
8-K
220otq4cibtsg
25 Jul 23
Submission of Matters to a Vote of Security Holders
4:02pm